Loading…
Transcript

EXAM

Jan. 8th 2018, 1100 - SBV 107 & 108

Aspect of curriculum

Something of key importance to project.

Something missing in the project?

Something you know well?

An interesting article to draw upon?

Relation to recent exams?

Chose a model from the course?

Options

3 Value proposition and business plan generation

5 market and company analysis

6 marketing and implementation analysis

8 financial planning

9 IPR, partnering, and contracting

11 corporate governance: management & ownership

Specifications

2 minutes presentation

+

3 minutes discussion

Specifications

Aspects of the business plan

Pricing

Clinical testing of personalized treatments

Major assumptions

We can build an in silico-platform

Our assays are superior to current solutions

The Assay advantage can be translated to in-silico advantage

The Assay advantage can be translated to in-sili...

Screening immunigenicity of neoepitopes is important for therapeutic cancer vaccines

Screening immunigenicity of neoepitopes is important f...

There is a market for therapeutic cancer vaccines

Major flaws

Vague about the imidiate steps

There seem to be big and unclear present----cancervaccine gap, more than a clear road leading from present to cancervaccine.

Similar to road sign saying (gold - walk 250 miles that way)

Not explicit assumptions

Who is the business plan directed at

Lacking support for superiority assumption

Lacking support for the struggle of choosing target neoepitopes

Lacking support for the struggle of choosing targ...

Lack of references

Not a clear target market

Little discussion of IMMUNIX competitive advantage

Value, Rareity, Imitability, Organization.

What are the disagvantages?

- one sided?

Ex. when discussing partnering.

The IPR issues are key and not discussed.

- Risk of spill-over

The IPR issues are key and not discussed.

- Risk of spi...

Risk of collaborators taking over.

articles

S3 Can you say what your STRATEGY is

..in 35 words

Basic elements of STRATEGY:

objective

scope

advantage

"strategic sweet spot"

S3 dynamics in business models

Dynamics in business models are shaped by newly founded population and by change in business models of incumbents.

s5 understanding industry context

Text book about understanding the context of a business.

Business analysis to business succes gap

s5 Market analysis (biodesign 2.4)

s6 marketing planning: a seven-stage process

From marketing philosophy to marketing control

s6 marketing and stakeholder strategy

s8 valuation in life-science

s8 valuation of early stage high-tech start-up companies

s9 an explorative analysis of patent fencing in pharmaceuticals

s9 an explorative analysis of patent fenci...

Patent fencing (within PDE5 inhibitors)

s9 - profiting from technological innovation

3 bulding blocks

appropriability regime

complementary assets

dominant design paradigme

s11 - the firms strategic dynamics and corporate governance life cycle

s11 - the firms strategic dynamics and corpora...

s11 - the innovative enterprise and corporate governance

s11 - the innovative enterprise and corpora...

Business plan

Improvements

Direction of business plan

Businessplan for partners

More tech-heavy

More focused Immunitrack solving their problems adding value to their products.

Business plan for investors

Business plan for hires

Business plan for internal understanding

Supporting major assumptions

Interviews

stakeholders

eksperter

Interviews

Feedback on business plan

Discussing how to prove supperiority

Discus how we target customers

Discuss current financial situation

The science

MHC molecules

Cancer treatments

CAR-T cell therapies

checkpoint inhibitors